Acute myeloid leukaemia (in remission) Recruiting Phase 1 Trials for Rituximab (DB00073)

Also known as: Acute Myeloid Leukemia in Remission / Acute myeloid leukemia (in remission) / Acute myeloblastic leukemia, in remission / Acute myeloid leukaemia in remission

IndicationStatusPhase
DBCOND0006975 (Acute myeloid leukaemia (in remission))Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02960646Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic MalignanciesTreatment